Most Recent
Two class actions against the state of Queensland over the removal of Indigenous children from their families are set to be discontinued after losing litigation funding.
Boral's former CEO Zlatko Tordorcevski and ex-CFO Tino La Spina have been granted discovery as they mull possible claims against their former employer for curbing their long-term incentive entitlements when they left in 2022.
Pharmacor, which is facing infringement claims by AstraZeneca over its plans to launch a generic version of diabetes drug Forxiga, can tweak its cross-claim to challenge a patent term extension.
A union has lost an appeal of a decision which found packaging company Opal Packaging was allowed to reintroduce drug and alcohol testing of staff under a new methodology while a union challenge was on foot.
Construction PRO
A judge has thrown out a law firm's bid to review a costs assessment manager's decision to grant a Sydney silk more time to make a costs assessment application for services he provided almost a decade ago.
EnergyAustralia has lost its appeal of a finding that it's on the hook for portable long service leave for maintenance workers at its Yallourn power station because its significant maintenance activities mean it's 'in the construction industry', a ruling that could affect energy, rail and telecommunications firms.
Two Sydney University academics facing discrimination suits over alleged antisemitic statements have argued proposed amendments risk blowing up the cases into "another royal commission".
Construction PRO
EnergyAustralia has lost its appeal of a finding that it's on the hook for portable long service leave for maintenance workers at its Yallourn power station because its significant maintenance activities mean it's 'in the construction industry', a ruling that could affect energy, rail and telecommunications firms.
Pharmacor has accused AstraZeneca of launching a royal commission into emails with its lawyers as AstraZeneca opposes the generic drug maker's bid to amend its pleading in a patent case over diabetes drug Forxiga.
Construction PRO
Dexus and Boral have entered a joint venture to develop the Ravenhall Logistics precinct in Melbourne's west.